Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Disposition to Issuer of 498,773 CPRX shares, $15.71M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 498,773 | $15.71M |
| Dec 30, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,334 | n/a |
| Dec 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,413 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 947 | n/a |
| Feb 19, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 4,000 | n/a |
| Jan 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 50,000 | $112.0K |
| Dec 31, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,333 | n/a |
| Dec 11, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 1,413 | n/a |
| Nov 25, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 23,248 | n/a |
| Feb 16, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 4,000 | n/a |